Name
ISIS 2503
Alternate Names
None
Abbreviations
None
Category
Other therapy
Subcategory
Antisense compound
did not receive FDA approval
NSC Number
718878
Primary Site
Histology
None
Remarks
Phase II, Phase II NSCLC Antisense anti RAS protein. ISIS Pharmaceuticals.
Coding
This drug should be coded